Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/54942
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
Author: Imai, C.
Mihara, K.
Andreansky, M.
Nicholson, I.
Pui, C.
Geiger, T.
Campana, D.
Citation: Leukemia, 2004; 18(4):676-684
Publisher: Nature Publishing Group
Issue Date: 2004
ISSN: 0887-6924
1476-5551
Statement of
Responsibility: 
C Imai, K Mihara, M Andreansky, I C Nicholson, C-H Pui, T L Geiger and D Campana
Abstract: To develop a therapy for drug-resistant B-lineage acute lymphoblastic leukemia (ALL), we transduced T lymphocytes with anti-CD19 chimeric receptors, consisting of an anti-CD19 single-chain variable domain (reactive with most ALL cases), the hinge and transmembrane domains of CD8alpha, and the signaling domain of CD3zeta. We compared the antileukemic activity mediated by a novel receptor ('anti-CD19-BB-zeta') containing the signaling domain of 4-1BB (CD137; a crucial molecule for T-cell antitumor activity) to that of a receptor lacking costimulatory molecules. Retroviral transduction produced efficient and durable receptor expression in human T cells. Lymphocytes expressing anti-CD19-BB-zeta receptors exerted powerful and specific cytotoxicity against ALL cells, which was superior to that of lymphocytes with receptors lacking 4-1BB. Anti-CD19-BB-zeta lymphocytes were remarkably effective in cocultures with bone marrow mesenchymal cells, and against leukemic cells from patients with drug-resistant ALL: as few as 1% anti-CD19-BB-zeta-transduced T cells eliminated most ALL cells within 5 days. These cells also expanded and produced interleukin-2 in response to ALL cells at much higher rates than those of lymphocytes expressing equivalent receptors lacking 4-1BB. We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.
Keywords: T-cell receptor; CD137; acute lymphoblastic leukemia; B-cell lymphoma
RMID: 0020091949
DOI: 10.1038/sj.leu.2403302
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.